
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
| Publishes | Monthly | Episodes | 51 | Founded | 4 years ago |
|---|---|---|---|---|---|
| Categories | Health & FitnessEducationMedicine | ||||

1. RAS as an oncogene
2. The undruggable RAS
3. KRAS G12C as a specific exception
4. Daroxonrasib as a pan RAS(On) inhibitor
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook... more
1. Nomenclature, unique considerations
2. Secretory Syndromes
3. Somatostatin directed therapy
4. Peptide Receptor Radionucleotide Therapy
Citations
As always, citations, and sources include education from our respective training programs, the D... more
1. Etiologies and epidemiology
2. Staging and local/regional considerations
3. Systemic Therapy
4. Differences in immune checkpoint sensitivity by etiology
Citations
As always, citations, and sources include education from our respective training p... more
1. Stage II Disease
2. Overview of BEP, EP, VIP
3. Advanced, refractory disease
4. Survivorship considerations
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.co... more
Very extensively covers all the details yet put so comprehensively. Love listen to talking about tumors.
These two know their stuff!
I really appreciate these short and sweet podcasts filled with enough information (and all references) to brush up / stay up to date on the current treatment landscapes in various tumour types. Super clear & informative, without getting lost in too many details. Thank you!
I’m an oncology trainee (equal to a resident in the US I think) from Sweden and find this podcast incredibly useful. I love how important clinical trials and oncology bread and butter knowledge is presented in a very clear and systematic fashion which provides the listener with a solid foundation on which to build upon. I also appreciate how the hosts do something as rare as critically interprets and mentions weaknesses of the clinical trials they present which increases the scientific level and... more
Key themes from listener reviews, highlighting what works and what could be improved about the show.









Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Focused on educating medical professionals, particularly residents and fellows, this show offers a comprehensive examination of oncology topics related to tumor management. Each episode features discussions about different types of cancers and their unique treatment approaches, highlighting both established practices and the latest research in the field. The depth of information on chemotherapy and immunotherapy, combined with practical insights into clinical practice, makes it a vital resource for anyone looking to strengthen their understanding of oncology. Notably, the hosts emphasize evidence-based medicine and clinical guidelines, ensuring that the content is both relevant and applicable to real-world situations in oncology care.
Rephonic provides a wide range of podcast stats for Talking About Tumors with Ryann and Ryan. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Talking About Tumors with Ryann and Ryan and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Talking About Tumors with Ryann and Ryan, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Talking About Tumors with Ryann and Ryan, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Talking About Tumors with Ryann and Ryan has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Talking About Tumors with Ryann and Ryan:
Talking About Tumors with Ryann and Ryan launched 4 years ago and published 51 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Talking About Tumors with Ryann and Ryan from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Talking About Tumors with Ryann and Ryan. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.